MERCK Kommanditgesellschaft auf Aktien (MKGAF) CEO Belen Garijo on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/07/21
Merck's KEYTRUDA® (pembrolizumab) Significantly Prolonged Recurrence-Free Survival (RFS) Compared to Placebo as Adjuvant Therapy for Patients With Stage II Resected High-Risk Melanoma in Phase 3 KEYNOTE-716 TrialBusiness Wire • 08/05/21
Merck & Co., Inc. (MRK) CEO Rob Davis on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 07/29/21
Merck Announces Appointment of Cristal N. Downing as Chief Communications & Public Affairs OfficerBusiness Wire • 07/29/21
Merck Stock Falls As Q2 Earnings Lag Wall Street Estimates, Trimmed FY21 Guidance Below ConsensusBenzinga • 07/29/21
Merck stock slips after adjusted profit matches expectations, while revenue beatsMarket Watch • 07/29/21
Domino's, Eli Lilly, McDonald's, Merck and More Tuesday Afternoon Analyst Upgrades and Downgrades24/7 Wall Street • 07/27/21
Merck's Keytruda Combo Trial Meets Overall Survival Endpoint In PD-L1 Expressing Breast Cancer PatientsBenzinga • 07/27/21